Litigation Details for CELGENE CORPORATION v. BRECKENRIDGE PHARMACEUTICAL, INC. (D.N.J. 2020)
✉ Email this page to a colleague
CELGENE CORPORATION v. BRECKENRIDGE PHARMACEUTICAL, INC. (D.N.J. 2020)
| Docket | ⤷ Start Trial | Date Filed | 2020-03-10 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-04-27 |
| Cause | 15:1126 Patent Infringement | Assigned To | Esther Salas |
| Jury Demand | None | Referred To | Michael A. Hammer |
| Parties | BRECKENRIDGE PHARMACEUTICAL, INC. | ||
| Patents | 10,555,939; 6,561,976; 8,198,262; 8,204,763; 8,828,427; 9,993,467 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in CELGENE CORPORATION v. BRECKENRIDGE PHARMACEUTICAL, INC.
Details for CELGENE CORPORATION v. BRECKENRIDGE PHARMACEUTICAL, INC. (D.N.J. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-03-10 | External link to document | |||
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
